Physician profile
Kay Moua
NPI 1073890737
$1,447.79
in general payments reported to CMS, 2019-2025
13 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $65.13 · 2022: $154 · 2023: $293 · 2024: $624 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400 · Travel and Lodging: $11.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
| Travel and Lodging | $11.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $605.32 | 2022-2025 | Minimed 780g |
| Tandem Diabetes Care, INC. | $547.36 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $55.17 | 2021-2024 | |
| Lilly USA, LLC | $46.86 | 2023-2024 | Mounjaro, Zepbound |
| Abbott Laboratories | $44.16 | 2022 | |
| Roche Diabetes Care, INC. | $33.09 | 2021 | |
| Nevro Corp. | $26.20 | 2023 | Senza |
| Sequel Med Tech, LLC | $17.17 | 2025 | Twiist |
| Xeris Pharmaceuticals, INC. | $16.72 | 2023 | Gvoke Hypopen |
| Beta Bionics, INC. | $16.50 | 2024 | Ilet Bionic Pancreas |
| Novo Nordisk INC | $14.11 | 2024 | |
| Cequr Corporation | $13.50 | 2022 | |
| Insulet Corporation | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kay Moua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.